Shareable Research Card

LFCR - LIFECORE BIOMEDICAL, INC. \DE\ Return On Equity

This metric view shows LFCR - LIFECORE BIOMEDICAL, INC. \DE\ return on equity history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: 2019
Latest reported value
-15%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 May 2020
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: 2019.
  • Latest reported value on this page: -15%.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Return On Equity

New fact period available

Latest reported return on equity: -15%. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 May 2020

Page type

Metric history

Latest period

2019

SEC-backed company facts were refreshed from filings filed on 24 Apr 2026.

Benchmark Context

How Return On Equity compares with peers

LIFECORE BIOMEDICAL, INC. \DE\ is outside the visible top 120 companies for return on equity in the current sample.

Compared with

Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Return On Equity is down about 8677% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2015 to 31 Mar 2026.
  • Nearby companies in this sample: Wellgistics Health, Inc. and XCF Global, Inc..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Financial Metric Page

LIFECORE BIOMEDICAL, INC. \DE\: Return On Equity

Latest period: 2019. Period end: 31 May 2020. Units: %. Frequency: annual and quarterly.

Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

What This Metric Tells You

  • Shows the reported level of return on equity over 29 May 2011 - 31 May 2020.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 42 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use annual sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 Wellgistics Health, Inc. (wgrx) 141760% Quarter - 31 Dec 2025 Open Wellgistics Health, Inc. Return On Equity
2 XCF Global, Inc. (safx) 77635% Year - 31 Dec 2025 Open XCF Global, Inc. Return On Equity
3 Cardiff Lexington Corp (cdix) 49573% Year - 31 Dec 2025 Open Cardiff Lexington Corp Return On Equity
4 Bionik Laboratories Corp. 46191% Quarter - 31 Mar 2023 Open Bionik Laboratories Corp. Return On Equity
5 Savara Inc (svra) 43610% Quarter - 31 Dec 2025 Open Savara Inc Return On Equity
6 Athenex, Inc. 25553% Quarter - 31 Dec 2022 Open Athenex, Inc. Return On Equity

Metric Details

Metric
Return On Equity (ROE)
Taxonomy
ratio
Units tracked
%
Frequency coverage
annual and quarterly
History range
29 May 2011 - 31 May 2020
Facts on this page
42
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2019 -15% -15% -8677% 27 May 2019 31 May 2020
2018 0.17% -11% -98% 28 May 2018 26 May 2019
2017 11% +6.3% +129% 29 May 2017 27 May 2018
2016 4.9% +10% 30 May 2016 28 May 2017
2015 -5.4% -12% -178% 01 Jun 2015 29 May 2016
2014 6.9% -4.3% -38% 26 May 2014 31 May 2015
2013 11% -4.2% -27% 27 May 2013 25 May 2014
2012 15% 28 May 2012 26 May 2013

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2019 -1.7% -11% -119% 27 May 2019 25 Aug 2019
Q2 2019 0.16% -10% -98% 25 Feb 2019 26 May 2019
Q1 2019 2.6% -6.4% -71% 26 Nov 2018 24 Feb 2019
Q4 2018 8.6% +4.9% +130% 27 Aug 2018 25 Nov 2018
Q3 2018 9.2% +5.1% +122% 28 May 2018 26 Aug 2018
Q2 2018 10% +5.5% +116% 26 Feb 2018 27 May 2018
Q1 2018 9% +3.1% +52% 27 Nov 2017 25 Feb 2018
Q4 2017 3.8% +9.3% 28 Aug 2017 26 Nov 2017
Q3 2017 4.2% +9.4% 29 May 2017 27 Aug 2017
Q2 2017 4.8% +10% 27 Feb 2017 28 May 2017
Q1 2017 5.9% +11% 28 Nov 2016 26 Feb 2017
Q4 2016 -5.5% -11% -196% 29 Aug 2016 27 Nov 2016
Q3 2016 -5.2% -12% -181% 30 May 2016 28 Aug 2016
Q2 2016 -5.4% -12% -184% 01 Mar 2016 29 May 2016
Q1 2016 -5.6% -12% -184% 30 Nov 2015 28 Feb 2016
Q4 2015 5.8% -2.3% -28% 31 Aug 2015 29 Nov 2015
Q3 2015 6.5% -1.8% -22% 01 Jun 2015 30 Aug 2015
Q2 2015 6.3% -3.5% -35% 02 Mar 2015 31 May 2015
Q1 2015 6.6% -3.5% -35% 01 Dec 2014 01 Mar 2015
Q4 2014 8% -1.6% -16% 01 Sep 2014 30 Nov 2014
Q3 2014 8.4% -4.6% -36% 02 Jun 2014 31 Aug 2014
Q2 2014 9.8% -3.5% -26% 24 Feb 2014 25 May 2014
Q1 2014 10% -2.7% -21% 25 Nov 2013 23 Feb 2014
Q4 2013 9.6% -3.7% -28% 26 Aug 2013 24 Nov 2013
Q3 2013 13% +2.8% +28% 27 May 2013 25 Aug 2013
Q2 2013 13% +4.6% +53% 25 Feb 2013 26 May 2013
Q1 2013 13% +7.8% +155% 26 Nov 2012 24 Feb 2013
Q4 2012 13% +10% +302% 27 Aug 2012 25 Nov 2012
Q3 2012 10% +7.7% +319% 28 May 2012 26 Aug 2012
Q2 2012 8.7% +5.8% +205% 27 Feb 2012 27 May 2012
Q1 2012 5% 28 Nov 2011 26 Feb 2012
Q4 2011 3.3% 29 Aug 2011 27 Nov 2011
Q3 2011 2.4% 28 May 2011 28 Aug 2011
Q2 2011 2.8% 28 Feb 2011 29 May 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .